Related Experiment Video
Updated: Jun 2, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Sample Size Determination for Response-Adaptive Randomization With Recurrent Event Responses and Unequal Follow-Up
Junjiang Zhong1, Xianggao Hu2, Jingya Gao3
1School of Mathematics and Statistics, Xiamen University of Technology, Xiamen, China.
This study introduces sample size calculation methods for clinical trials using a doubly biased coin design (DBCD). The new procedure accounts for unequal follow-up times and patient dropouts, preventing underestimation of required sample sizes.
Area of Science:
- Clinical Trials
- Biostatistics
- Medical Research Methodology
Background:
- Recurrent event data are common in clinical trials, and the doubly biased coin design (DBCD) has shown benefits.
- Existing literature lacks comprehensive methods for sample size determination specifically for DBCD.
- Patient dropout and unequal follow-up times can significantly impact trial outcomes and sample size calculations.
Purpose of the Study:
- To develop and present methods for calculating sample size for clinical trials employing DBCD.
- To propose a sample size determination procedure that accommodates unequal follow-up times due to patient dropout.
- To quantify the impact of dropouts on sample size and treatment allocation.
Main Methods:
- Development of theoretical methods for sample size computation under DBCD.
- Incorporation of unequal follow-up times and patient dropout into the sample size determination procedure.
- Derivation of theoretical results to assess the influence of dropouts on sample size and allocation ratios.
Main Results:
- The proposed methods provide accurate sample size calculations for DBCD, considering unequal follow-up.
- Failure to account for patient dropout leads to an underestimation of the required sample size.
- Theoretical results quantify the impact of dropouts on both sample size and treatment allocation proportions.
Conclusions:
- The developed sample size determination procedure is crucial for the validity of clinical trials using DBCD.
- The procedure accurately accounts for patient dropout and unequal follow-up, ensuring adequate statistical power.
- Simulation studies and a clinical example demonstrate the practical utility and advantages of the proposed method.
More Related Videos
Related Concept Videos
Assumptions of Survival Analysis
Censoring Survival Data
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Randomized Experiments
Simple randomization
Simple...
Comparing the Survival Analysis of Two or More Groups
Sample Size Calculation
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...

